Rikke Borg

Rikke Borg

Clinical Associate Professor

Member of:

  • Internal Medicine: Nephrology

ORCID: 0000-0002-2283-3578

Publication year:
All
11 - 20 out of 27Page size: 10
  1. 2022
  2. Published

    Non-albuminuric chronic kidney disease in diabetes: A different approach?

    Borg, Rikke & Persson, F., 2022, In: The Indian Journal of Medical Research. 156, 4&5, p. 685-686 2 p.

    Research output: Contribution to journal › Comment/debate › Research

  3. 2021
  4. Published

    A narrative review of new treatment options for chronic kidney disease in type 2 diabetes

    Persson, F., Borg, Rikke & Rossing, Peter, 1 Apr 2021, In: Annals of Translational Medicine. 9, 8, p. 716-716 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Early improvements in pulmonary function after severe COVID-19 requiring mechanical ventilation

    Bonnesen, B., Toennesen, L. L., Rasmussen, K. B., Nessar, R., Nielsen, H. B., Hildebrandt, T., Sloth, C., Baylarova, T. A. G., Moerch, S. S. & Borg, Rikke, 2021, In: Infectious Diseases. 53, 3, p. 218-221 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  6. Published

    The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis

    Bomholt, T., Idorn, T., Knop, Filip Krag, Jørgensen, M. B., Ranjan, A. G., Resuli, M., Hansen, P. M., Borg, Rikke, Persson, F., Feldt-Rasmussen, Bo & Hornum, Mads, 2021, In: Nephron. 145, 1, p. 27-34

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. 2018
  8. Published

    HYPOGLYCAEMIC EPISODES EVALUATED BY CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH TYPE 2 DIABETES AND DIALYSIS-DEPENDENT END-STAGE RENAL DISEASE RANDOMISED TO 12-WEEK LIRAGLUTIDE OR PLACEBO TREATMENT

    Bomholt, T., Idorn, T., Knop, Filip Krag, Jorgensen, M. B., Resuli, M., Christensen, Karl Bang, Hansen, P. M., Borg, Rikke, Persson, F., Feldt-Rasmussen, Bo & Hornum, Mads, May 2018, In: Nephrology Dialysis Transplantation. 33, suppl_1, p. 492-492 SP426.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  9. Published

    Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database

    Borg, Rikke, Persson, F., Siersma, Volkert Dirk, Lind, B., de Fine Olivarius, N. & Andersen, Christen Bertel L, 2018, In: Diabetic Medicine. 35, 12, p. 1700-1706 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Potassium chloride mixture may maintain hypokalaemia and hypertension

    Mandoe, M. J., Borg, Rikke & Hansen, Ditte, 2018, In: BMJ Case Reports. 11, 1, e223732.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA 1c in individuals with and without diabetes

    Færch, K., Alssema, M., Mela, D. J., Borg, Rikke & Vistisen, D., 2018, In: Nutrition and Diabetes. 8, p. 1-9 9 p., 38.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    YKL-40 in dialysis patients

    Persson, F. & Borg, Rikke, 2018, In: Kidney International. 93, 1, p. 21-22

    Research output: Contribution to journal › Comment/debate › Research

  13. 2017
  14. Published

    Empagliflozin reduces albuminuria: a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial

    Borg, Rikke & Persson, F., 2017, In: Journal of Translational Medicine. 5, 23, 4 p., 478.

    Research output: Contribution to journal › Editorial › Research

Previous 1 2 3 Next

ID: 173692562